Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kropp

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Nuklearmedizin. Nuclear Medicine|August 1, 1991
[A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas]B Briele, A Hotze, J Kropp, et al.
Annals of Nuclear Medicine|December 7, 2000
18F-FDG for the staging of patients with differentiated thyroid cancer: comparison of a dual-head coincidence gamma camera with dedicated PETC Tiepolt, B Beuthien-Baumann, R Hliscs, et al.
European Journal of Nuclear Medicine|January 11, 1991
Single photon emission tomography imaging of myocardial oxidative metabolism with 15-(p-[123I]iodophenyl) pentadecanoic acid in patients with coronary artery disease and aorto-coronary bypass graft surgeryJ Kropp, J Likungu, P G Kirchhoff, et al.
British Journal of Haematology|February 15, 2002
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphomaR Naumann, A Vaic, B Beuthien-Baumann, et al.
The New England Journal of Medicine|June 20, 1985
Influence of prognosis on decisions regarding the care of newborns with myelodysplasiaJ F McLaughlin, D B Shurtleff, J Y Lamers, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 15, 2000
Rhenium-188-HEDP in the palliative treatment of bone metastasesK Liepe, R Hliscs, J Kropp, et al.
Cancer Detection and Prevention|February 24, 2001
Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course studyW G Franke, K Zöphel, G R Wunderlich, et al.
Nuklearmedizin. Nuclear Medicine|July 28, 2001
Accuracy of the intra-operative radioguided localization of the sentinel lymph node (SLN) 24 hours after lymphoscintigraphy in patients with malignant melanomaJ Kropp, A Stein, I Hackert, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
FDA Engages Collaborators to Address Nonclinical Data ChallengesTimothy J Kropp, Lilliam A Rosario, Susan DeHaven, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 1999
Dual-label studies with [125I]-3(R)/[131I]-3(S)-BMIPP show similar metabolism in rat tissuesF T Mokler, Q Lin, H Luo, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Nuklearmedizin. Nuclear Medicine|August 1, 1991
[A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas]B Briele, A Hotze, J Kropp, et al.
Annals of Nuclear Medicine|December 7, 2000
18F-FDG for the staging of patients with differentiated thyroid cancer: comparison of a dual-head coincidence gamma camera with dedicated PETC Tiepolt, B Beuthien-Baumann, R Hliscs, et al.
European Journal of Nuclear Medicine|January 11, 1991
Single photon emission tomography imaging of myocardial oxidative metabolism with 15-(p-[123I]iodophenyl) pentadecanoic acid in patients with coronary artery disease and aorto-coronary bypass graft surgeryJ Kropp, J Likungu, P G Kirchhoff, et al.
British Journal of Haematology|February 15, 2002
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphomaR Naumann, A Vaic, B Beuthien-Baumann, et al.
The New England Journal of Medicine|June 20, 1985
Influence of prognosis on decisions regarding the care of newborns with myelodysplasiaJ F McLaughlin, D B Shurtleff, J Y Lamers, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 15, 2000
Rhenium-188-HEDP in the palliative treatment of bone metastasesK Liepe, R Hliscs, J Kropp, et al.
Cancer Detection and Prevention|February 24, 2001
Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course studyW G Franke, K Zöphel, G R Wunderlich, et al.
Nuklearmedizin. Nuclear Medicine|July 28, 2001
Accuracy of the intra-operative radioguided localization of the sentinel lymph node (SLN) 24 hours after lymphoscintigraphy in patients with malignant melanomaJ Kropp, A Stein, I Hackert, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
FDA Engages Collaborators to Address Nonclinical Data ChallengesTimothy J Kropp, Lilliam A Rosario, Susan DeHaven, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 1999
Dual-label studies with [125I]-3(R)/[131I]-3(S)-BMIPP show similar metabolism in rat tissuesF T Mokler, Q Lin, H Luo, et al.
Pageof 10